MedPath
NMPA Approval

Regorafenib Tablets

国药准字H20243057

January 16, 2024

Drug Information

瑞戈非尼片

片剂

40mg(按C₂₁H₁₅ClF₄N₄O₃计)

化学药品

January 16, 2024

Company Information

Applicant Company

上海市浦东新区惠南镇沪南公路9125号

Manufacturing Company

上海市浦东新区惠南镇沪南公路9125号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

瑞戈非尼片 - NMPA 批准文号 | MedPath